WO2001085979A2 - Stabilized composition - Google Patents
Stabilized composition Download PDFInfo
- Publication number
- WO2001085979A2 WO2001085979A2 PCT/US2001/014395 US0114395W WO0185979A2 WO 2001085979 A2 WO2001085979 A2 WO 2001085979A2 US 0114395 W US0114395 W US 0114395W WO 0185979 A2 WO0185979 A2 WO 0185979A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- indicator
- stabilized
- hydroperoxide
- composition
- peroxidase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
Definitions
- the present invention relates generally to the field of biochemical assays for detecting the presence of peroxidase or other peroxidatively active substances. More specifically, it relates to stabilized indicator compositions employed for use in wet chemical techniques employed for such analyses.
- Peroxidase is an enzymatic hemoprotein which catalyzes the oxidation by hydroperoxides of a number of substrates. Of particular interest among the substrates are dyes possessing leuco forms which are colorless prior to oxidation. Under properly controlled conditions, the amount of oxidative coloration will be proportional to the amount of peroxidase activity .
- the hydrogen donor may be chosen from the class of indicators which emit light or exhibit otlier detectable characteristics in the oxidized state. Hydroperoxides typically used include hydrogen peroxide, methyl peroxide and ethyl peroxide.
- peroxidase and peroxidase-like activity has utility in a variety of medically related fields. Assays based on peroxidase activity have provided a powerful tool in the immunobiological field, especially in the detection of certain proteins. In the area of cytochemistry, the detection of such activity can be used to identify and monitor certain cell types. Peroxidatively active substances are present in a restricted set of cell types including myeloid leukocytes and granulocyte, erythrocytes, and certain neurons and secretory cells. Mitotic cells also exhibit
- Such strips comprise a porous insoluble matrix strip first
- the indicator is oxidized, typically changing color.
- the "dip-and- read" teclinique has the advantage of being particularly easy to use but obviously, cannot be used
- the protein-antibody-peroxidase complex may be detected by
- antinuclear antibodies maybe detected in human serum through the use of the peroxidase redox reaction.
- HEp-2 cells, transfected HEp-2 cells as described in U.S. Patent No. 5,518,881, or other suitable cells are fixed onto a slide, and then the cells are contacted with a serum which may contain antinuclear antibodies directed against cellular components, particularly, but not limited to, nuclear antigens. If present in the serum, the antibodies will react with antigens within the HEp-2 cells forming an immune complex. After washing off the excess serum, the immune complexes within the cells are then further reacted with a solution containing antihuman immunoglobulins conjugated with peroxidase enzyme.
- the antihuman immunoglobulin conjugate is specific for the immune complexes formed in the HEp-2 cells so that the peroxidase enzyme will be present on the slide after washing excess solution away only if antinuclear antibodies were present in the serum. Finally, the reacted cells fixed to the slide are contacted with a chromogenic indicator in a buffered aqueous solution which also contains hydroperoxide, so that the peroxidase-catalyzed reaction may occur.
- the HEp-2 cells will be colored only to the extent that antinuclear antibodies were present in the serum reacted with the HEp-2 cells.
- other antigen reactions such as for nucleic acids, cellular cytoplasmic components, or proteins associated with infectious agents may be detected.
- certain frequently used and desirable indicators notably 4-chloro-l-naphthol and 3-amino-9-ethylcarbazole, are insoluble in water. Accordingly, theses types of compounds must first be dissolved in an organic solvent such as alcohol or dimethylsulfoxide to effect solubilization of the indicator before further mixing with the aqueous medium. These reagent solutions must also be prepared immediately prior to use as the indicator may precipitate out of solution upon standing.
- the present invention provides an improved indicator composition for use in wet method
- dry powdered indicator composition is readily activated by
- the reagent in both the dry, pre-activated state, as well as in the aqueous, activated form remains stable and active over a wide temperature range, thereby obviating the need
- the reactivity of the indicator composition is substantially greater
- a stabilized indicator composition such as is described in
- U. S. Patent No. 4,615,972 is combined with an organic hydroperoxide that exists in a dry state and physiologic buffering while all components are in their dry state.
- the resulting stability is most unexpected in view of the well-known instability of many hydroperoxides that only exist in liquid forms and which often exist only as short-lived intermediate products in organic chemical reactions.
- the resulting stability of the combination is further unexpected in view of the dry organic peroxide ' s instability while in its uncombined form.
- urea peroxide is air, light, and moisture sensitive and unstable at room temperature. Such compound must normally be stored under argon at 2-8 °C.
- the stabilized indicator compound and organic peroxide are intermixed, the dry powder may be maintained in the laboratory at ambient temperature over long periods of time.
- the indicator solution is achieved by simply the addition of deionized water which again achieves a most unexpected result in view of the organic hydroperoxide ' s instability and moisture sensitivity.
- the indicator composition is stable for an indefinite period of time.
- the indicator composition of the present invention is used to detect the presence of peroxidase or peroxidase-like substances.
- the composition comprises a stable dry powder and is readily converted to its activated aqueous state by simply the addition of deionized water.
- the composition is highly stable both in its dry state as well as in solution. Additionally, the composition offers much greater sensitivity than was realized using heretofore hydrogen peroxide based indicator systems.
- the selected indicator is combined with a water soluble polymer such as polyethylene glycol, polyethyleneoxide or polyvinylpyrrolidone and derivatives thereof, by mixing and grinding.
- a water soluble polymer such as polyethylene glycol, polyethyleneoxide or polyvinylpyrrolidone and derivatives thereof.
- the two compounds are first mixed with a paddle and then ground together, either with a mortar and pestle or a ball mill for thirty minutes while cold (4° -8° C).
- the amount of the indicator combined with the stabilizer is not critical, although a ratio of about 1 part of indicator to about 250 parts of stabilizer by weight, has been found effective. Acceptable results have been obtained with stabilizers having a range of molecular weight between 8,000 and 100,000 Daltons, but it is believed that higher and lower molecular weights will also produce acceptable results.
- Polyethylene glycol has been
- the solid indicator and the stabilizer do not mix uniformly, particularly when large quantities are mixed together, an even distribution can be obtained by first mixing the indicator with a salt such as sodium chloride, and then combining the mixture with the stabilizer as described previously.
- a salt such as sodium chloride
- Sodium chloride is preferred, in a weight ratio of about 12 parts salt to 1 part indicator, since saline solutions are widely utilized in assay procedures.
- the procedure according to this approach is to mix the indicator and salt and then to grind the mixture in a mortar and pestle for about 10 minutes or a ball mill for about 30 minutes.
- the solid product is then mixed with the stabilizer and ground together as described previously.
- the final stabilized indicator powder may be used in the same manner as a powder wherein no salt is used.
- the organic hydroperoxide also while in its dry state, is added. Only hydroperoxides that exist in a dry state have been found to exhibit the unexpected stability.
- the dry hydroperoxide is intermixed at low temperature (4-8°C).
- Optimal stability performance has been realized by combining the two reagents in a ratio of about 1 :600 by weight of urea hydroperoxide (carbamide hydroxyperoxide) to powder. A working concentration from 0.05 to 0.25 mM final concentration of urea hydroperoxide was found to be most effective.
- non-liquid organic hydroperoxides besides urea hydroperoxide offer similar advantages in terms of stability and sensitivity.
- benzoyl hydroperoxide (activated) or sodium percarbonate can readily be substituted for the urea hydroperoxide and suggest that any non- liquid organperoxide would work equally well.
- the stabilized indicator powders from EXAMPLES 1-6 were placed in clear plastic sealed ners and subjected to accelerated aging for fifteen days at 43 °C, equivalent to three years at refrigerated temperature. No evidence of oxidation or deterioration of the stabilized indicator powders was found.
- the aged powders form EXAMPLE 7 were each dissolved in a ratio of 3 grams per 100 ml of phosphate buffered saline and stored for an additional week in a clear plastic container at 43 °C,
- the buffered stabilized indicator powders from EXAMPLE 9 were placed in clear plastic sealed containers and subjected to accelerated aging for fifteen days at 43 °C, equivalent to three years at refrigerated temperature. There was no evidence of oxidation or deterioration of the stabilized indicator powders.
- the slide was immersed in the appropriate solution under evaluation for 30 minutes and the excess staining solution rinsed away using phosphate buffered saline and placed immediately in a deionized water solution. Each slide was removed from the water and excess water eliminated by tapping the slide on an absorbent paper. The slides were mounted with a glass coverslip using mounting solution. The slides were evaluated using a light microscope (400X) for the presence and intensity of color staining of the HEp-2 cells. Slides were evaluated by multiple experienced technologists.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2001261182A AU2001261182A1 (en) | 2000-05-05 | 2001-05-04 | Stabilized composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56542200A | 2000-05-05 | 2000-05-05 | |
US09/565,422 | 2000-05-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001085979A2 true WO2001085979A2 (en) | 2001-11-15 |
WO2001085979A3 WO2001085979A3 (en) | 2002-03-21 |
Family
ID=24258519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/014395 WO2001085979A2 (en) | 2000-05-05 | 2001-05-04 | Stabilized composition |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001261182A1 (en) |
WO (1) | WO2001085979A2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4615972A (en) * | 1983-11-04 | 1986-10-07 | Immuno Concepts, Inc. | Stabilization of indicators for detecting enzyme activity |
US5206150A (en) * | 1990-10-26 | 1993-04-27 | University Of Kentucky Research Foundation | Composition of, method of producing and method of using a stabilized formulation for assaying peroxidase activity |
US5334502A (en) * | 1991-11-27 | 1994-08-02 | Osborn Laboratories, Inc. | Method of collecting, identifying, and quantifying saliva |
-
2001
- 2001-05-04 WO PCT/US2001/014395 patent/WO2001085979A2/en active Application Filing
- 2001-05-04 AU AU2001261182A patent/AU2001261182A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4615972A (en) * | 1983-11-04 | 1986-10-07 | Immuno Concepts, Inc. | Stabilization of indicators for detecting enzyme activity |
US5206150A (en) * | 1990-10-26 | 1993-04-27 | University Of Kentucky Research Foundation | Composition of, method of producing and method of using a stabilized formulation for assaying peroxidase activity |
US5334502A (en) * | 1991-11-27 | 1994-08-02 | Osborn Laboratories, Inc. | Method of collecting, identifying, and quantifying saliva |
Also Published As
Publication number | Publication date |
---|---|
WO2001085979A3 (en) | 2002-03-21 |
AU2001261182A1 (en) | 2001-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0161281B1 (en) | Stabilization of indicators for detecting enzyme activity | |
EP0230229B1 (en) | Stable composition for the determination of peroxidatively active substances | |
JP2922003B2 (en) | Improved compositions, tools and methods for assaying for peroxide active substances | |
US3595755A (en) | Detection of hydrogen peroxide | |
JP3131924B2 (en) | Improved methods and reagents for analyte measurement | |
WO1985005688A1 (en) | Assay of peroxidase enzyme activity | |
EP0152847B1 (en) | Stabilized enzyme conjugate composition | |
JPH0640837B2 (en) | Composition for measuring alcohol | |
WO2001085979A2 (en) | Stabilized composition | |
US5804404A (en) | Stable substrate-chromogen solutions for enenzyme activity detection | |
US4782023A (en) | Stabilized horseradish peroxidase conjugate composition | |
JPS61181399A (en) | Conduction of enzyme assay and chemical composition for conducting the same | |
EP0586397B1 (en) | Improved method and reagent for determination of an analyte | |
JP3403407B2 (en) | Control reagents containing hydroxylamine or antioxidants | |
US5215885A (en) | Stable two-part chromogen substrate | |
JP3711544B2 (en) | Chemiluminescence measuring reagent | |
EP0811844B1 (en) | Reagent composition, testing piece and assay kit | |
US5910423A (en) | Water soluble powered formulation of reagent mixture containing water-insoluble reagents, and process for their production | |
Nathan | Release of hydrogen peroxide | |
JP2694004B2 (en) | Method for measuring fructosamine in serum or plasma | |
CS208781B2 (en) | Method of determination of the bonding index in the blood serum | |
EP1000358A1 (en) | Pre-stained 3,3',5,5'-tetramethylbenzidine substrates for the detection of enzyme activity | |
Zhuang et al. | N‐(β‐Carboxypropionyl) luminol as a new chemiluminescence label in immunoassay | |
JPS63277654A (en) | Dicyanoethylaryl derivative and test reagent containing same | |
JPH0980050A (en) | Enzyme-labeled antibody solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase in: |
Ref country code: JP |